The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancer

References

• Scattoni V, Raber M, Abdollah F, et al. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy. Eur Urol. 2010;57:1–8.
   PubMed Web of Science ®Google Scholar
• Franiel T, Stephan C, Erbersdobler A, et al. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding-multiparametric MR imaging for detection and biopsy planning. Radiology. 2011;259:162–172.
   PubMed Web of Science ®Google Scholar
• Ukimura O, Coleman JA, de la Taille A, et al. Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol. 2013;63:214–230.
   PubMed Web of Science ®Google Scholar
• Panebianco V, Barchetti F, Sciarra A, et al. Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol. 2015;33:17.e1–17.
   PubMed Web of Science ®Google Scholar
• Nelson AW, Harvey RC, Parker RA, et al. Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy. PLoS One. 2013;8:e57480.
   PubMed Web of Science ®Google Scholar
• Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64:876–892.
   PubMed Web of Science ®Google Scholar
• Delongchamps NB, Haas GP. Saturation biopsies for prostate cancer: current uses and future prospects. Nat Rev Urol. 2009;6:645–652.
   PubMed Web of Science ®Google Scholar
• Fütterer JJ, Briganti A, De Visschere P, et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol. 2015;68:1045–1053.
   PubMed Web of Science ®Google Scholar
• Delongchamps NB, Peyromaure M, Schull A, et al. Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol. 2013;189:493–499.
   PubMed Web of Science ®Google Scholar
• Valerio M, Donaldson I, Emberton M, et al. Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol. 2015;68:8–19.
   PubMed Web of Science ®Google Scholar
• Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22:746–757.
   PubMed Web of Science ®Google Scholar
• Moore CM, Kasivisvanathan V, Eggener S, et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol. 2013;64:544–552.
   PubMed Web of Science ®Google Scholar
• Mozer P, Rouprêt M, Le Cossec C, et al. First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer. BJU Int. 2015;115:50–57.
   PubMed Web of Science ®Google Scholar
• Baco E, Rud E, Eri LM, et al. A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy. Eur Urol. 2016;69:149–156.
   PubMed Web of Science ®Google Scholar
• Salami SS, Ben-Levi E, Yaskiv O, et al. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? BJU Int. 2015;115:562–570.
   PubMed Web of Science ®Google Scholar
• Sonn GA, Chang E, Natarajan S, et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol. 2014;65:809–815.
   PubMed Web of Science ®Google Scholar
• Fiard G, Hohn N, Descotes J-L, et al. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion. Urology. 2013;81:1372–1378.
   PubMed Web of Science ®Google Scholar
• Siddiqui MM, Rais-Bahrami S, Truong H, et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol. 2013;64:713–719.
   PubMed Web of Science ®Google Scholar
• Kuru TH, Roethke MC, Seidenader J, et al. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol. 2013;190:1380–1386.
   PubMed Web of Science ®Google Scholar
• Moore CM, Robertson NL, Arsanious N, et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol. 2013;63:125–140.
   PubMed Web of Science ®Google Scholar
• Portalez D, Mozer P, Cornud F, et al. Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol. 2012;62:986–996.
   PubMed Web of Science ®Google Scholar
• Puech P, Ouzzane A, Gaillard V, et al. Multiparametric MRI-targeted TRUS prostate biopsies using visual registration. BioMed Res Int. 2014;2014:819360.
   PubMedGoogle Scholar
• Wysock JS, Rosenkrantz AB, Huang WC, et al. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol. 2014;66:343–351.
   PubMed Web of Science ®Google Scholar
• Radtke JP, Kuru TH, Boxler S, et al. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. J Urol. 2015;193:87–94.
   PubMed Web of Science ®Google Scholar
• Ma TM, Tosoian JJ, Schaeffer EM, et al. The role of multiparametric magnetic resonance imaging/ultrasound fusion biopsy in active surveillance. Eur Urol. 2017;71:174–180.
   PubMed Web of Science ®Google Scholar
• Pepe P, Garufi A, Priolo G, et al. Transperineal versus transrectal MRI/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer. Clin Genitourin Cancer. 2017;15:e33–e36.
   PubMedGoogle Scholar
• Ukimura O, Marien A, Palmer S, et al. Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies. World J Urol. 2015;33:1669–1676.
   PubMed Web of Science ®Google Scholar
• Filson CP, Natarajan S, Margolis DJA, et al. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies. Cancer. 2016;122:884–892.
   PubMed Web of Science ®Google Scholar
• Baco E, Ukimura O, Rud E, et al. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Eur Urol. 2015;67:787–794.
   PubMed Web of Science ®Google Scholar
• Hu JC, Chang E, Natarajan S, et al. Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? J Urol. 2014;192:385–390.
   PubMed Web of Science ®Google Scholar
• Ukimura O, Gross ME, de Castro Abreu AL, et al. A novel technique using three-dimensionally documented biopsy mapping allows precise re-visiting of prostate cancer foci with serial surveillance of cell cycle progression gene panel. Prostate. 2015;75:863–871.
   PubMed Web of Science ®Google Scholar
• Thomas C, Roos FC, Thüroff JW. Systematic biopsy, targeted biopsy or a combination-how should we detect prostate cancer in the future? J Urol. 2015;193:10–11.
   PubMed Web of Science ®Google Scholar
• Emberton M. Are men who are biopsied without prior prostate magnetic resonance imaging getting substandard care? BJU Int. 2015;116:837–839.
   PubMed Web of Science ®Google Scholar